{'fraction_non_alphanumeric': 0.030947775628626693, 'fraction_numerical': 0.0019342359767891683, 'mean_word_length': 5.556962025316456, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Pharmacologic aspects of AIDS].

The recent findings of the research on the acquired immune deficiency syndrome (AIDS) are reviewed. They provide information about the epidemiological, genetical and morphological features of the human immunodeficiency virus (HIV) and HIV-like viruses, in particular, HTLB-1. Special attention was paid to the pharmacological aspects of preventing AIDS and its spreading among the population. Some new concepts and approaches to the elaboration of therapeutic measures are discussed.